Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes
Clinical trial NCT01342692 · UNKNOWN
Trial details
- NCT number
- NCT01342692
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2018-07-01
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.